Cite
Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care)
MLA
Messager, M., et al. Description and Analysis of Clinical Pathways for Oesophago-Gastric Adenocarcinoma, in 10 European Countries (the EURECCA Upper Gastro Intestinal Group - European Registration of Cancer Care). Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ebc9d9682fac518903b33c68bbec07a1&authtype=sso&custid=ns315887.
APA
Messager, M., de Steur, W., Boelens, P. G., Jensen, L. S., Mariette, C., Reynolds, J. V., Osorio, J., Pera, M., Johansson, J., Kołodziejczyk, P., Roviello, F., De Manzoni, G., Moenig, S. P., Allum, W. H., & EURECCA Upper GI group (European Registration of Cancer Care). (2016). Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
Chicago
Messager, M, W de Steur, P G Boelens, L S Jensen, C Mariette, J V Reynolds, J Osorio, et al. 2016. “Description and Analysis of Clinical Pathways for Oesophago-Gastric Adenocarcinoma, in 10 European Countries (the EURECCA Upper Gastro Intestinal Group - European Registration of Cancer Care),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ebc9d9682fac518903b33c68bbec07a1&authtype=sso&custid=ns315887.